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Nfkb2 variants reveal a p100-degradation threshold
that defines autoimmune susceptibility
Rushika C. Wirasinha1*, Ainsley R. Davies2,3,4*, Monika Srivastava2, Julie M. Sheridan5,6, Xavier Y.X. Sng1, Ottavia M. Delmonte7,
Kerry Dobbs7, Khai L. Loh1, Lisa A. Miosge2, Cindy Eunhee Lee2,3, Rochna Chand2,3, Anna Chan1, Jin Yan Yap2, Michael D. Keller8,
Karin Chen9,10, Jamie Rossjohn1,11,12, Nicole L. La Gruta1, Carola G. Vinuesa2,4, Hugh H. Reid1,11, Michail S. Lionakis13,
Luigi D. Notarangelo7, Daniel H.D. Gray5,6, Christopher C. Goodnow14, Matthew C. Cook2,3,4**, and Stephen R. Daley1**
NF-κB2/p100 (p100) is an inhibitor of κB (IκB) protein that is partially degraded to produce the NF-κB2/p52 (p52)
transcription factor. Heterozygous NFKB2 mutations cause a human syndrome of immunodeficiency and autoimmunity, but
whether autoimmunity arises from insufficiency of p52 or IκB function of mutated p100 is unclear. Here, we studied mice
bearing mutations in the p100 degron, a domain that harbors most of the clinically recognized mutations and is required for
signal-dependent p100 degradation. Distinct mutations caused graded increases in p100-degradation resistance. Severe p100-
degradation resistance, due to inheritance of one highly degradation-resistant allele or two subclinical alleles, caused thymic
medullary hypoplasia and autoimmune disease, whereas the absence of p100 and p52 did not. We inferred a similar
mechanism occurs in humans, as the T cell receptor repertoires of affected humans and mice contained a hydrophobic signature
of increased self-reactivity. Autoimmunity in autosomal dominant NFKB2 syndrome arises largely from defects in
nonhematopoietic cells caused by the IκB function of degradation-resistant p100.
Introduction
Rare mutations in NFKB2 cause an autosomal dominant human
syndrome of hypogammaglobulinemia and increased suscepti-
bility to infections, often accompanied by organ-specific auto-
immunity (Chen et al., 2013; Klemann et al., 2019; Lee et al.,
2014). Key insights into immunological mechanisms of health
and disease have come from analysis of rare Mendelian human
syndromes (Cheng and Anderson, 2012). Accurate mousemodels
of these syndromes have been informative and provide a means
to elucidate cell types in which the mutations act to cause pa-
thology, with implications for therapy in humans. In the human
NFKB2 syndrome, autoimmune manifestations are frequent but
heterogenous (Klemann et al., 2019), and the determinants of
susceptibility to autoimmunity are unknown.
The NF-κB family comprises five proteins: RelA, RelB, c-Rel,
NF-κB1 (p105/p50), and NF-κB2 (p100/p52). Full-length NF-
κB2/p100 (p100) dimerizes with other NF-κB family members
and binds preformed NF-κB dimers, inhibiting their function
until the signal-dependent degradation of p100 releases active
NF-κB dimers (Basak et al., 2007; Scheinman et al., 1993; Sun
et al., 1994). In resting cells, p100 serves as the core of high-
molecular-weight, cytoplasmic complexes called kappaBsomes,
which contain all NF-κB members (Savinova et al., 2009; Tao
et al., 2014). Degradation of p100 requires noncanonical NF-κB
activation induced by engagement of cell-surface receptors,
predominantly of the tumor necrosis factor receptor super-
family (Sun, 2017). This leads to intracellular accumulation of
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NF-κB–inducing kinase (NIK), which cooperates with IκB kinase
α (IKKα) to phosphorylate the p100 degron at specific sites
(Ser866, Ser870, and possibly Ser872) before ubiquitination of
Lys855, tagging the C-terminal portion of p100 for proteasomal
removal (Liang et al., 2006; Sun, 2012; Xiao et al., 2001). Het-
erozygousmutations that truncate the NF-κB2 precursor protein
proximal to the degron, enabling signal-independent production
of NF-κB2/p52 (p52), have been found in patients with immu-
nodeficiency or cytopenias (Klemann et al., 2019; Kotlinowski
et al., 2019; Kuehn et al., 2017). Most of the clinically recognized
NFKB2 mutations, including all those variants identified in pa-
tients with alopecia areata, hypopituitarism, and/or serum au-
toantibodies, cluster in the p100 degron (Klemann et al., 2019).
All tested p100 degron mutations confer a decrease in p52
abundance (Chen et al., 2013; Kuehn et al., 2017; Lee et al., 2014;
Lindsley et al., 2014; Liu et al., 2014; Maccari et al., 2017;
Ramakrishnan et al., 2018; Slade et al., 2019), and pathology has
been proposed to arise from p52 insufficiency (Chen et al., 2013;
Klemann et al., 2019). However, some effects of NFKB2 degron
mutations, such as cytoplasmic retention of RelA (Lee et al.,
2014) and reduced cytokine release in response to LPS stimu-
lation (Kuehn et al., 2017), cannot be explained by p52 insuf-
ficiency and are consistent with exaggerated IκB function of
mutated p100. The contributions of these two mechanisms to
autoimmune susceptibility are unclear.
Studies of mice with Nfkb2 mutations indicate that p52
insufficiency and IκB function of mutated p100 both cause au-
toimmune manifestations, albeit differing in severity. Nfkb2−/−
mice, which lack p100 and p52, exhibit inflammatory infiltrates
in multiple organs (Zhu et al., 2006) but have a near-normal
lifespan (O’Reilly et al., 2015). Nfkb2Lym1 encodes a mutant p100
protein (p.Y868*) that is truncated in the p100 degron (Tucker
et al., 2007). In Nfkb2Lym1/Lym1 cells, p100 is detectable, but p52 is
not (Tucker et al., 2007). During noncanonical NF-κB activation,
newly synthesized p100 is predominantly processed into p52,
whereas most of the preexisting p100 undergoes complete deg-
radation (Yilmaz et al., 2014). In contrast, noncanonical NF-κB
activation causes p100 to accumulate in Nfkb2Lym1/Lym1 cells,
demonstrating that themutation inhibits the partial and complete
degradation of p100 (Tucker et al., 2007). On the BALB/c genetic
background, Nfkb2Lym1/Lym1 mice developed extensive inflamma-
tory infiltrates in the lung and liver and had a shortened lifespan,
while Nfkb2+/Lym1 mice had milder inflammation and no increase
in mortality up to 250 d of age (Tucker et al., 2007). AIRE-
expressing medullary thymic epithelial cells (mTECs) are pre-
sent but reduced in Nfkb2−/− mice (O’Reilly et al., 2015; Zhu et al.,
2006), while thymic expression of Aire mRNA is markedly re-
duced in Nfkb2Lym1/Lym1 mice (Tucker et al., 2007). AIRE is re-
quired for the expression and presentation of tissue-specific
antigens in the thymus andmutations in AIRE cause autoimmune
polyendocrine syndrome type I (Proekt et al., 2017). NFKB2 mu-
tations have been proposed to confer susceptibility to autoim-
munity by causing a deficiency of AIRE (Chen et al., 2013;
Klemann et al., 2019; Lee et al., 2014; Liu et al., 2014;
Ramakrishnan et al., 2018; Shi et al., 2016). Whether and how
NFKB2/Nfkb2 mutations predispose to autoimmunity by mecha-
nisms distinct from diminishing AIRE expression is unclear.
Here, we analyzed a murine Nfkb2 allelic series, including a
strain carrying an allele orthologous to the variant identified in
our index patient (Lee et al., 2014). We found that some Nfkb2
degron mutations conferred moderate p100-degradation resis-
tance, which did not trigger spontaneous autoimmunity in
heterozygous mice. However, homozygosity for subclinical al-
leles, or one copy of the Nfkb2Lym1 allele, caused thymic med-
ullary hypoplasia and fully penetrant, fatal, multiorgan
autoimmunity in C57BL/6 (B6) mice. These effects were distinct
from those caused by the absence of p100 and p52 or AIRE. The
TCR repertoires of autoimmunity-prone strains were enriched in
hydrophobicmotifs, a biomarker of self-reactivity (Stadinski et al.,
2016), and a similar abnormality was present in patients with
NFKB2 mutations.
Results
Decreased lifespan of mice with mutations in the p100 degron
The N-terminal portion of p100 is p52 (aa ∼1–405; Betts and
Nabel, 1996), which contains a Rel homology domain, a feature
of all NF-κB members (Fig. 1 A). The C-terminal portion of p100
contains a helix-turn-helix domain (aa 435–481) and an ankyrin
repeat domain (aa 490–752) that mediate IκB activity (Savinova
et al., 2009; Sun et al., 1994; Tao et al., 2014) and a processing
inhibitory domain (aa 753–849) that inhibits signal-independent
(aberrant) processing of p100 into p52 (Xiao et al., 2001). On the
other hand, signal-dependent processing of p100 into p52 re-
quires the p100 degron (aa 850–900; Xiao et al., 2001). 16 of the
21 pathogenic NFKB2mutations identified thus far cluster in the
p100 degron (Fig. 1 A; Klemann et al., 2019).
To investigate immunological effects of p100 degron muta-
tions, we used CRISPR/Cas9 gene editing to generate mice with
an allele (Nfkb2D865G) orthologous to the variant identified in our
index patient (Lee et al., 2014; Fig. 1 D and Fig. S1 A). The gene
editing procedure also generated other variants. TheNfkb2Ser866fs
allele is predicted to encode a lengthened p100 protein in which
the 49 C-terminal amino acids are altered. The Nfkb2Y868indel
variant is predicted to cause a net deletion of one residue be-
tween Ser866 and Ser870. To enable comparison with estab-
lished models, we studied mice bearing the Nfkb2+/Lym1 allele
(Tucker et al., 2007) or the Nfkb2xdr allele, in which an intronic
substitution disrupts splicing of Nfkb2 mRNA and prevents ex-
pression of p100 and p52 (Miosge et al., 2002). All strains had a
B6 genetic background.
As the human NFKB2 syndrome is autosomal dominant, we
studied mice with heterozygous Nfkb2 mutations. While most
strains had a normal lifespan, Nfkb2+/D865G mice had a slight
reduction in lifespan compared withNfkb2+/+ control mice (Fig. 1
B and Fig. S1 B). B6.Nfkb2+/Lym1 mice had a markedly shortened
lifespan with a median survival of 215 d (Fig. 1 B), shorter than
previously observed in BALB/c.Nfkb2+/Lym1 mice (Tucker et al.,
2007). This is remarkable because autoimmune manifestations
in B6.Aire−/− mice are milder than in BALB/c.Aire−/− mice (Jiang
et al., 2005).
To study effects of Nfkb2 mutations in the absence of WT
p100 and p52, homozygous mutant mice were examined. At-
tempts to study Nfkb2Lym1/Lym1 mice were unsuccessful, because
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Figure 1. Decreased lifespan in mice with Nfkb2 genotypes that result in above-threshold p100 accumulation relative to p52 (see also Fig. S1).
(A) Cartoon of human NF-κB2, showing its domains and known pathological variants. (B and C) Lifespans of WT mice compared with mice that were het-
erozygous (B) or homozygous (C) for the indicated Nfkb2 or Aire genotypes. Small vertical lines indicate observations censored for reasons unrelated to illness.
See Fig. S1 B for statistical analyses. (D) Nfkb2 alleles studied in this paper. See Fig. S1 A for DNA sequence chromatograms. (E) Nfkb2 genotype affects p100
and p52 expression. Spleen lysates were subjected to SDS-PAGE followed by immunoblotting with an antibody reactive with p100 and p52 or GAPDH as a
loading control. Graphs (right) show the density of p100 or p52 normalized to GAPDH for each sample and then divided by the mean of Nfkb2+/+ control
samples on the same gel. Far right graph shows the p100/p52 ratio, excluding Nfkb2xdr/xdr samples, in which the p100 and p52 densities were below the limit of
detection. Each symbol on a graph represents an individual mouse, determined as the mean of one to five technical replicates. Vertical dashed lines mark the
mean of the Nfkb2+/+ group. Data from female and male mice were comparable and were pooled from 26 experiments. Nfkb2S866fs/S866fsmice (mean ± SD, 372 ±
289 d; range, 61–614 d) were older than Nfkb2+/+ mice (mean ± SD, 163 ± 99 d; range, 60–571 d); otherwise, ages were not significantly different from the
Nfkb2+/+ group. Each genotype was compared with the Nfkb2+/+ group using one-way ANOVA with Dunnett’s post-test; *, P < 0.05; **, P < 0.01; ***, P < 0.001;
****, P < 0.0001. (F) For the indicated mouse strains (far right), the graphs show the time to 20% mortality plotted against the mean p100 density (left), mean
p52 density (middle), or mean p100/p52 ratio (right), annotated with P and r values calculated using Pearson’s test for correlation.
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all offspring ofNfkb2+/Lym1 females died before weaning (data not
shown), possibly due to a lactation defect akin to that observed
in mice with hypomorphic mutations in IKKα (Cao et al., 2001).
Nfkb2D865G/D865G and Nfkb2Y868indel/Y868indel mice had markedly
shortened lifespans, with a median survival of 170 d and 128 d,
respectively (Fig. 1 C). Compared with WT mice, lifespan was
also shortened in Nfkb2xdr/xdr mice, but not in Nfkb2S866fs/S866fs or
Aire−/− mice (Fig. 1 C and Fig. S1 B).
To assess effects of Nfkb2 mutations on the abundance of
p100 and p52, spleen lysates were analyzed by immunoblotting.
In humans, recognized p100 degron mutations result in normal
or increased abundance of p100, whereas the abundance of p52 is
decreased (Fig. S1 C). This combination of changes was observed
in four genotypes: Nfkb2+/D865G, Nfkb2D865G/D865G, Nfkb2+/Lym1, and
Nfkb2Y868indel/Y868indel (Fig. 1 E). Similar results were obtained for
the Nfkb2+/Y868indel genotype, but the trend toward a decrease in
p52 abundance was not statistically significant. Those findings
suggest that the p100D865G, p100Lym1, and p100Y868indel proteins
resist degradation. Notably, the p100 band in Nfkb2+/Lym1 samples
migrated faster than other samples, consistent with a truncation
in the p100Lym1 protein (Fig. 1 E).While no changes were detected
in the Nfkb2+/S866fs group, both p100 and p52 were decreased in
samples from Nfkb2S866fs/S866fs mice. Interestingly, in Nfkb2+/xdr
mice, the abundance of p100 was halved, whereas the p52 abun-
dance was not significantly different from WT. As expected, nei-
ther p100 nor p52 was detectable in Nfkb2xdr/xdr samples.
We hypothesized that the p100/p52 ratio may indicate the
extent to which the p100 protein pool in each strain resists
processing into p52. Consistent with this hypothesis, in mice
bearing the Nfkb2D865G or Nfkb2Y868indel alleles, the absence of WT
p100 protein in homozygous mutant mice resulted in a higher
p100/p52 ratio than in heterozygous mutant mice (Fig. 1 E). The
p100/p52 ratio in heterozygousNfkb2+/Lym1 samples was comparable
to that in homozygous Nfkb2D865G/D865G and Nfkb2Y868indel/Y868indel
samples, suggesting that p100Lym1 is more resistant to degrada-
tion than the p100D865G and p100Y868indel proteins. Combining
the data thus far, lifespan was not correlated with the abundance
of either p100 or p52 but was negatively correlated with the
p100/p52 ratio (Fig. 1 F).
T cell–dependent multiorgan autoimmunity caused by p100
degron mutations
The reduction in lifespan described above was T cell dependent,
as Tcra−/− Nfkb2+/Lym1 mice remained healthy (Fig. 2 A). At ne-
cropsy, Nfkb2+/Lym1 mice had dilated intestines and small pan-
creases, consistent with exocrine pancreatitis (Fig. 2, B and C).
Nfkb2+/Lym1mice commonly developed dermatitis on the face and
ears, accompanied occasionally by vitiligo (Fig. 2 D). Histology
revealed severe exocrine pancreatitis in all Nfkb2D865G/D865G,
Nfkb2+/Lym1, and Nfkb2Y868indel/Y868indel mice, but not inNfkb2xdr/xdr
mice (Fig. 2, E and F; and data not shown). Previous studies
revealed mild to moderate lymphocytic infiltrates in liver and
lung, but not exocrine pancreatitis, in B6.Nfkb2−/− mice (O’Reilly
et al., 2015; Zhu et al., 2006). Inflammatory infiltrates were also
common in the lacrimal glands, salivary glands, liver, and lung
of Nfkb2D865G/D865G and Nfkb2+/Lym1 mice (Fig. 2, E and F).
Nfkb2+/Lym1 mice also had inflammatory infiltrates in small
exocrine glands that line the ear canal and prepuce (data not
shown). Some humans with NFKB2 mutations have central ad-
renal insufficiency (Brue et al., 2014), but pituitary gland his-
tology in Nfkb2+/Lym1 mice was normal (data not shown).
Pancreatitis was uncommon in B6.Aire−/− mice, whereas prostate
and retina were affected, as described previously (Jiang et al.,
2005; Leonard et al., 2017; Taniguchi et al., 2012; Fig. 2, E and F).
Mice with mutations in the p100 degron thus developed T cell–
mediated autoimmunity, which affected a set of organs distinct
from those affected by the absence of p100 and p52 or AIRE.
Thymic tolerance defects in mice with p100 degron mutations
In a WT mouse, more than half of the nascent thymic lympho-
cytes (thymocytes) that receive a detectable αβ TCR signal un-
dergo apoptosis at the CD4+ CD8+ double-positive (DP) stage, or
before up-regulation of the chemokine receptor, CCR7 (wave
1 deletion; Daley et al., 2013; Sinclair et al., 2013; Stritesky et al.,
2013). To test whether Nfkb2 mutations affect wave 1 deletion,
we quantified nascent thymocytes that received a strong TCR
signal in mice carrying an antiapoptotic, B cell lymphoma
2 transgene (BCL2-tg; Ogilvy et al., 1999; Wirasinha et al., 2019;
Fig. 3 A). To identify nascent thymocytes, mice were injected
once with 5-ethynyl-29-deoxyuridine (EdU), which is taken up
by thymocytes that are proliferating just before the onset of αβ
TCR expression (Lucas et al., 1993). At 3 d after EdU injection,
Nfkb2+/D865G mice had normal frequencies of EdU+ thymocytes
and TCR-signaled CD5+ TCRβ+ cells (Saini et al., 2010; Fig. S2, A
and B). In Nfkb2+/D865G mice with normal apoptosis, the fre-
quencies of strongly TCR-signaled Helios+ CCR7− cells and
weakly TCR-signaled Helios− CCR7+ cells were normal (Fig. 3 B).
However, when apoptosis was inhibited by BCL2-tg expression,
Nfkb2+/D865G mice had decreased Helios+ CCR7− cell induction
and increased Helios− CCR7+ cell induction (Fig. 3 B). Similar
results were obtained in Nfkb2+/Lym1 mice (Fig. 3 C and Fig. S2, C
and D). Thus, only the Nfkb2+/Lym1 genotype caused autoimmu-
nity, but the Nfkb2+/D865G and Nfkb2+/Lym1 genotypes both de-
creased the number of thymocytes that received a strong TCR
signal and increased the number of thymocytes that received a
weak TCR signal at the wave 1 checkpoint.
At the subsequent stage of development, strong TCR signal-
ing induces some CD4+ CD8− CCR7+ thymocytes to up-regulate
Helios as they commit to undergo deletion (wave 2 deletion) or
up-regulate Foxp3 (Hu et al., 2016, 2017). To quantify strongly
TCR-signaled cells at the wave 2 checkpoint, we analyzed thy-
mocytes 5 d after EdU injection, when wave 2 deletion peaks in
EdU+ thymocytes (Hu et al., 2016; Fig. 3 D). Sequential gating of
thymocytes that were EdU+, CD5+ TCRβ+, CD4+ CD8− (CD4 single
positive [CD4SP]), and Helios− CCR7+ revealed increased in-
duction of weakly TCR-signaled cells in Nfkb2+/Lym1 and Aire−/−
mice (Fig. 3 E and Fig. S2, E–G). The induction of Helios+ CCR7+
cells was decreased in Nfkb2+/D865G and Nfkb2+/Lym1 mice, but not
in Nfkb2xdr/xdr mice (Fig. 3 E). A caveat with this result is that the
Nfkb2xdr/xdr mice were significantly younger than the mice in
other groups, which may have contributed to the greater Helios+
CCR7+ cell frequencies detected in Nfkb2xdr/xdr mice compared
with control mice (Fig. 3 E). Analysis of bulk CD4SP thymocytes
revealed a decreased frequency and number of Foxp3+
Wirasinha et al. Journal of Experimental Medicine 4 of 19
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regulatory T cells (T reg cells) in Nfkb2+/D865G, Nfkb2+/Lym1 and
Aire−/− mice, but not in Nfkb2xdr/xdr mice (Fig. 3 F). A single copy
of the Nfkb2D865G or Nfkb2Lym1 allele was thus sufficient to
strongly decrease TCR-signaled thymocyte populations at the
wave 1 and 2 checkpoints and decrease the thymic T reg cell
population.
T cell–extrinsic and intrinsic defects in T reg
cell differentiation
During Foxp3+ T reg cell differentiation in CD4SP CCR7+ thy-
mocytes, the up-regulation of Helios and Foxp3 mark the onsets
of requirements for thymocyte-intrinsic c-Rel function (Daley
et al., 2013) and IL-2 signaling (Hu et al., 2017), respectively. To
test for T cell–extrinsic defects in T reg cell differentiation, ir-
radiated WT or mutant mice were reconstituted with WT bone
marrow (BM) and thymocytes from the chimeric mice were
examined 5–14 wk later. Among CD4SP CCR7+ thymocytes, the
frequencies of Helios+ Foxp3− and Foxp3+ cells were decreased
in Nfkb2+/D865G recipients, but not in Nfkb2xdr/xdr recipients
(Fig. 3 G). The frequency of Foxp3+ cells was decreased in Aire−/−
recipients of WT BM (Fig. 3 G). In a similar experiment designed
to “capture” cells that would otherwise undergo apoptosis, irra-
diated WT or mutant mice were reconstituted with BCL2-tg+ BM.
At 7–10 wk after transplantation, both Helios+ Foxp3− and Foxp3+
cells were decreased in Nfkb2+/Lym1 recipients, whereas only
Foxp3+ cells were decreased in Aire−/− recipients (Fig. 3 I). These
results establish that the capacity of nonhematopoietic cells to
induce strongly TCR-signaled Helios+ Foxp3− thymocytes at the
CD4SP CCR7+ stage is decreased in Nfkb2+/D865G and Nfkb2+/Lym1
mice in comparison to WT, Nfkb2xdr/xdr and Aire−/− mice.
To test for T cell–intrinsic defects in T reg cell differentiation,
we reconstituted irradiated CD451/1 mice with WT CD451/2 BM
Figure 2. T cell–dependent multiorgan autoimmunity caused by p100 degron mutations. (A) Lifespans of cohoused Tcra+/− Nfkb2+/Lym1 and Tcra−/−
Nfkb2+/Lym1 sibling mice (P value, log-rank test). Small vertical lines indicate observations censored for reasons unrelated to illness. (B) Abdominal viscera of
Nfkb2+/+ and Nfkb2+/Lym1 littermates aged 150 d. Yellow arrows indicate the pancreas, which is small in the Nfkb2+/Lym1 mouse; scale bar, 1 cm. (C) Pancreas
mass in Nfkb2+/+ and Nfkb2+/Lym1 mice stratified by sex. (D) A male Nfkb2+/Lym1 mouse aged 225 d with dermatitis on the face and ears and vitiligo; scale bar,
1 cm. (E) Histology of organs (denoted above) showing normal (top row) and affected (bottom row) tissue sections; scale bars, 100 µm. (F) Pathology score for
each organ colored by genotype, with bars showing the group mean. The number of mice per group is shown below the x axis. In F, the Aire−/−mice (mean ± SD,
182 ± 60 d; range, 92–272 d) were significantly older than the Nfkb2+/+mice (mean ± SD, 118 ± 43 d; range, 84–211 d). The ages of all other groups in F and the
Nfkb2+/Lym1 mice in C were not significantly different from the Nfkb2+/+ group. In A and F, data from female and male mice were comparable and therefore
pooled. For each sex in C or organ in F, each genotype was compared with the Nfkb2+/+ group using two-way ANOVA with Sidak’s post-test (C) or Kruskal-
Wallis tests with Dunn’s post-test (F); *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
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Figure 3. Diminished thymic tolerance mechanisms in mice with p100 degron mutations (see also Fig. S2). (A) Quantification of wave 1 deletion. At 3 d
after proliferating thymocytes incorporate EdU, nascent (EdU+) TCR-signaled (CD5+ TCRβ+) thymocytes were analyzed to resolve Helios+ CCR7− and Helios−
CCR7+ subsets, which have received a strong or weak TCR signal, respectively. BCL2-tg expression inhibits apoptotic deletion, enabling measurement of the
scale of wave 1 deletion. (B) Helios/CCR7 phenotypes of EdU+ CD5+ TCRβ+ thymocytes from Nfkb2+/+ or Nfkb2+/D865Gmice, which were negative or positive for
BCL2-tg (top), 3 d after EdU injection, with summaries (right) showing the frequencies of gated populations among EdU+ thymocytes. (C) Nfkb2+/+ and
Nfkb2+/Lym1 mice were examined as in B. The age ranges of mice were 68–94 d (B) and 40–70 d (C). (D) Quantification of thymocytes that received a weak or
Wirasinha et al. Journal of Experimental Medicine 6 of 19
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mixed with WT, Nfkb2+/Lym1, or Nfkb2xdr/xdr CD452/2 BM. In all
groups, the frequencies of CD452/2 cells among weakly TCR-
signaled CD4SP CCR7+ Helios− Foxp3− thymocytes were similar
to the frequencies of CD452/2 cells among their DP precursors
(Fig. 3 H), indicating that naive CD4+ T cell differentiation was
not impaired. However, chimeras bearing CD452/2 Nfkb2+/Lym1
BM had a lower CD452/2 cell frequency in the Helios+ Foxp3−
subset and a further decrease in the Foxp3+ subset (Fig. 3 H), in-
dicative of defects at both c-Rel–dependent and IL-2–dependent
stages of thymic T reg cell differentiation. In contrast, T reg cell
differentiation was not impaired in Nfkb2xdr/xdr cells, which actu-
ally showed enhanced differentiation to the c-Rel–dependent
Helios+ Foxp3− stage (Fig. 3 H). Together, the results in Fig. 3
show that the Nfkb2+/D865G and Nfkb2+/Lym1 genotypes conferred
T cell–extrinsic and intrinsic defects in thymic tolerance that were
not recapitulated by the Nfkb2xdr/xdr genotype, suggesting that
these defects arise predominantly from an exaggerated IκB func-
tion of mutant p100 proteins and not from insufficiency of p52.
Quantitative and functional T reg cell deficiencies conferred by
p100 degron mutations
Decreased T reg cell populations have been described in patients
with heterozygous NFKB2 mutations and homozygous AIRE
mutations (Klemann et al., 2019; Sng et al., 2019). We observed
that heterozygous NFKB2 mutations confer a greater T reg cell
defect than homozygous AIREmutations (Fig. 4 A and Table S1).
Except for the Nfkb2+/S866fs mice, all mouse strains with p100
degronmutations had a decreased Foxp3+ T reg cell frequency in
the spleen (Fig. 4 B). In contrast, Foxp3+ T reg cell frequency was
normal in Nfkb2xdr/xdr mice (Fig. 4 B), as observed in Nfkb2−/−
mice (O’Reilly et al., 2015; Zhu et al., 2006). Despite the T reg cell
deficiency, antigen-experienced CD44hi Foxp3− cells were not
increased in any mutant mouse strain; in fact, they were sig-
nificantly decreased in several strains (Fig. 4 B). Analysis of
mixed chimeras showed that the Nfkb2+/Lym1 genotype impaired
differentiation of splenic T reg cells and antigen-experienced
CD44hi Foxp3− cells in a cell-intrinsic manner, whereas the
Nfkb2xdr/xdr genotype did not (Fig. 4 C). Capacity for T reg cell
differentiation was increased in Nfkb2xdr/xdr cells, as observed
when the Nfkb2 gene is deleted specifically in T reg cells or all
T cells (Grinberg-Bleyer et al., 2018).
To test for cell-intrinsic defects in T reg cell function, WT
hosts were irradiated and reconstituted with Foxp3null/y BM
alone or Foxp3null/y BM mixed 1:1 with Nfkb2+/D865G BM or
Nfkb2+/Lym1 BM. All recipients of Foxp3null/y BM alone developed
disease due to the absence of Foxp3+ T reg cells (Fontenot et al.,
2003), whereas most of the chimeras that also received
Nfkb2+/D865G or Nfkb2+/Lym1 BM remained healthy for >100 d after
BM transplantation (Fig. 4 D). However, the antigen-experienced
CD44hi Foxp3− cell frequency in the Foxp3null/y CD4+ compart-
ment was increased inmice withNfkb2+/Lym1 T reg cells (Fig. 4 E).
Thus, while both Nfkb2+/D865G and Nfkb2+/Lym1 T reg cells can
suppress disease, Nfkb2+/Lym1 T reg cells are defective in the
trans-acting control of spontaneous CD4+ T cell activation.
Autoimmune susceptibility arises from effects within
nonhematopoietic cells
Susceptibility to autoimmunity arising from NFKB2/Nfkb2 mu-
tations could be due to effects within hematopoietic cells, in-
cluding T cells, and/or nonhematopoietic cells, which play a
crucial role in antigen presentation to developing thymocytes.
To distinguish between these possibilities, chimeras were made
in which T cell–depleted BM from Nfkb2+/+ or Nfkb2+/Lym1 donors
was transferred into irradiated Nfkb2+/+, Nfkb2+/D865G, or
Nfkb2+/Lym1 hosts. To prevent the onset of autoimmune disease
before the BM transplant, all hosts were αβ T cell–deficient
(Tcra−/−). Transplantation of Nfkb2+/Lym1 BM into WT recipients
did not cause disease (Fig. 5 A), indicating that the cell-intrinsic
defects in T reg cell development and function do not cause
autoimmunity when the nonhematopoietic compartment is
normal. In contrast, most of the Nfkb2+/Lym1 hosts that received
Nfkb2+/+ BM developed a fatal disease with a median survival
after BM transplantation of 49 d, significantly shorter than all
other groups (Fig. 5 A). This disease could be inhibited by ex-
ogenous T reg cells, as purified T reg cells injected 8 d after BM
transplantation rescued half of the Nfkb2+/Lym1 hosts bearing
Nfkb2+/+ BM (Fig. 5 B). No disease occurred in unirradiated
Tcra−/− Nfkb2+/Lym1 hosts that received Nfkb2+/+ splenocytes,
strong TCR signal at the wave 2 checkpoint. At 5 d after EdU injection, the EdU+ CD5+ TCRβ+ CD4SP population was analyzed to resolve Helios+ CCR7+ (strongly
TCR-signaled) and Helios− CCR7+ (weakly TCR-signaled) subsets. (E) Plots show the Helios/CCR7 phenotype of EdU+ CD5+ TCRβ+ CD4SP thymocytes from
mice of the indicated genotypes 5 d after EdU injection, with summaries showing the frequencies of gated populations among EdU+ thymocytes. The
Nfkb2xdr/xdr mice (45 d old) were significantly younger than the Nfkb2+/+ mice (mean ± SD, 86 ± 22 d; range 53–105 d). The ages of all other groups were not
significantly different from the Nfkb2+/+ group. (F) For the genotypes examined in E, plots show Foxp3/CCR7 phenotype of CD4SP thymocytes, with a graph
showing the frequency and number of Foxp3+ cells in the CD4SP population. Age of mice did not differ significantly between groups (mean ± SD, 84 ± 24 d;
range, 50–158 d). (G) Nfkb2+/+, Nfkb2+/D865G, Nfkb2xdr/xdr, Aire+/+, or Aire−/−mice aged 42–98 d were irradiated then reconstituted withWT BM. Graphs show the
frequencies of Helios+ Foxp3− and Foxp3+ cells among CD4SP CCR7+ thymocytes in the chimeric mice 5–14 wk after transplantation. (H)WTCD451/1 mice aged
57–145 d were irradiated then reconstituted with WT CD451/2 BM mixed with Nfkb2+/+, Nfkb2+/Lym1, or Nfkb2xdr/xdr CD452/2 BM. All donors and recipients were
male. 8–27 wk later, flow cytometry was used to determine the frequency of CD452/2 cells among DP thymocytes and among three subsets of CD4SP CCR7+
thymocytes defined by Helios and Foxp3 expression as gated in the plots. The graph shows the frequency of CD452/2 cells in the subsets indicated on the x axis,
divided by the frequency of CD452/2 cells among DP thymocytes in the same sample. To enable comparisons between CD4SP CCR7+ thymocyte subsets, data
were then divided by the mean of the Nfkb2+/+ group for each subset. (I) Nfkb2+/+, Nfkb2+/Lym1, Aire+/+, or Aire−/− mice aged 42–96 d were irradiated then
reconstituted with BCL2-tg+ BM. Graphs show the frequencies of Helios+ Foxp3− and Foxp3+ cells among CD4SP CCR7+ thymocytes in the chimeric mice 7–10 wk
after transplantation. Each symbol in a summary graph represents an individual mouse, and horizontal bars show the group means. Each graph shows data compiled
from one (G and I), two (B, C, and E), three (H), or eight (F) separate experiments. Unless otherwise stated, graphs show data from female and male mice. Statistical
comparisons used one-way (E and F) or two-way (B, C, and H) ANOVAwith Sidak’s multiple comparisons tests or Student’s t tests (G and I); *, P < 0.05; **, P < 0.01;
***, P < 0.001; ****, P < 0.0001.
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suggesting that T cell development in the Nfkb2+/Lym1 host
thymus was required to induce pathology. These data establish
that susceptibility to autoimmunity in Nfkb2+/Lym1 mice stems
from abnormalities in nonhematopoietic cells.
Impaired thymic medullary development in mice with p100
degron mutations
As autoimmunity arises when the Nfkb2+/Lym1 genotype is con-
fined to the nonhematopoeitic compartment, which includes
thymic epithelial cells (TECs), we characterized thymic struc-
ture. The histological demarcation between cortex and medulla
was unclear in Nfkb2D865G/D865G and Nfkb2Y868indel/Y868indel mice
(Fig. 6 A). Except for Nfkb2+/S866fs mice, which were similar to
WT (data not shown), the medullary area tended to be smaller in
all strains bearing mutations in the Nfkb2 degron (Fig. 6 B). In
contrast, thymus sections from Nfkb2xdr/xdr mice had clearly
demarcated regions of cortex and medulla with normal medul-
lary area (Fig. 6, A and B), as observed in Nfkb2−/− mice (Zhu
Figure 4. Quantitative and functional T reg cell deficiencies conferred by p100 degron mutations. (A) Plots show CD25/CD127 phenotypes of human
peripheral blood CD19− CD4+ CD8− cells, with a graph showing the CD25+ CD127− T reg cell frequency from healthy control subjects or patients with mutations
in NFKB2 or AIRE (see Table S1 for details). (B) Frequencies of Foxp3+ and CD44hi Foxp3− cells among CD4+ splenocytes in mice of the indicated genotypes. Age
of mice did not differ significantly between groups (mean ± SD, 119 ± 48 d; range, 51–219 d). (C) From mixed chimeras (described in Fig. 3 H) harboring WT
CD451/2 BM and WT, Nfkb2+/Lym1, or Nfkb2xdr/xdr CD452/2 BM; plots show the gates used to resolve three subsets of B220− CD4+ CD8− splenocytes based on
CD44/Foxp3 phenotype. The graph shows the frequency of CD452/2 cells in the subsets indicated on the x axis, divided by the frequency of CD452/2 cells among
CD44lo Foxp3− cells in the same sample. (D) Survival curves of Tcra−/− Nfkb2+/+ female mice after irradiation at 62–90 d of age followed by reconstitution with
CD451/2 Foxp3−/y BM alone or mixed 1:1 with CD451/1 Nfkb2+/D865G BM or CD451/1 Nfkb2+/Lym1 BM (see key, middle). All BM donors were male. Grid (right) shows
the P values of log-rank tests comparing each pair of experimental groups. (E) For the chimeras described in D at 106 d after transplantation, plots show the
gates used to determine the frequency of Foxp3+ and CD44+ Foxp3− cells among the CD451/2 and CD451/1 subsets of B220− CD4+ CD8− splenocytes, enu-
merated for multiple mice in the graph (right). Unless otherwise stated, graphs show data from female and male mice compiled from 1 (D and E), 3 (C), 5 (A), or
11 (B) separate experiments. Statistical comparisons used one-way (A and B) or two-way (C and E) ANOVA with Sidak’s multiple comparisons tests; *, P < 0.05;
**, P < 0.01; ****, P < 0.0001.
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et al., 2006). In all strains examined by immunofluorescence, we
found distinct regions of expression of cytokeratin-8 (K8) and
cytokeratin-14 (K14), which characterize the cortex andmedulla,
respectively (Fig. 6 C). The lectin Ulex Europaeus agglutinin
1 (UEA-1) binds to mature mTECs (Farr and Anderson, 1985).
UEA-1 staining was reduced in Nfkb2+/Lym1 and Nfkb2xdr/xdr mice
(Fig. 6 D). While AIRE was readily detected in Nfkb2+/+, Nfkb2+/D865G,
and Nfkb2xdr/xdr mice, AIRE+ cells were rare in thymic sections
from Nfkb2+/Lym1 mice (Fig. 6 E).
Flow cytometry revealed that the Nfkb2D865G allele caused a
dose-dependent reduction in the number of TECs, identified
as CD45− EpCAM+ cells, with the magnitude of the defect in
Nfkb2D865G/D865G mice similar to that observed in Nfkb2+/Lym1
mice (Fig. 6 F). Aire+ TECs were present but reduced in
Nfkb2+/D865Gmice, while these cells were rare in Nfkb2D865G/D865G
and Nfkb2+/Lym1 mice (Fig. 6 G). A single Nfkb2−/−mouse, which
was obtained for this experiment, had a clearly identifiable
Aire+ mTEC population, albeit reduced in frequency compared
with Nfkb2+/+ controls (Fig. 6 G). Consistent with the im-
munohistology, mature-phenotype UEA-1+ AIRE−mTECs were
decreased in Nfkb2+/Lym1 mice, as they were in Nfkb2D865G/D865G
mice (Fig. 6 G). Thymic B cells were decreased in Nfkb2+/D865G,
Nfkb2D865G/D865G, and Nfkb2+/Lym1 mice, and thymic dendritic cells
(DCs) were decreased in Nfkb2D865G/D865G and Nfkb2+/Lym1 mice
(Fig. 6 H). Overall, while UEA-1+ and Aire+ mTECs were reduced
in Nfkb2xdr/xdr and Nfkb2−/− mice, consistent with previous re-
ports (O’Reilly et al., 2015; Zhu et al., 2006), medullary size
and haemopoietic APCs were normal in these strains lacking
p100 and p52. In contrast, the Nfkb2+/Lym1, Nfkb2D865G/D865G, and
Nfkb2Y868indel/Y868indel genotypes caused a severe block in thymic
medullary development that affected both epithelial and
hematopoietic APCs.
Accumulation of pancreas-specific CD4+ T cells
In models of autoimmune exocrine pancreatitis, protein disul-
fide isomerase family A member 2 (PDIA2) is a self-antigen that
is targeted by B and T cells in NOD.Aire−/− mice and BALB/
c.Ctla4−/− mice, respectively (Ise et al., 2010; Niki et al., 2006).
To test whetherNfkb2mutations affect T cell tolerance to PDIA2,
we analyzed CD4+ T cells bound by tetramers of the MHC class II
molecule IAb, presenting a peptide corresponding to PDIA2
residues 83–93 (IAb-PDIA2; Malhotra et al., 2016). Compared
with Nfkb2+/+ controls, IAb-PDIA2–specific CD4+ T cell pop-
ulations were larger in Nfkb2+/Lym1 mice, but not in Nfkb2+/D865G
mice (Fig. 7 A). The IAb-PDIA2–specific CD4+ T cell population in
B6.Aire−/− mice was normal in size (Fig. 7 A); this was expected,
because B6.Aire−/− mice do not develop autoimmune exocrine
pancreatitis (Jiang et al., 2005). Tetramer staining intensity was
increased in Nfkb2+/Lym1 mice (Fig. 7 A), suggesting that many of
the expanded CD4+ T cells had a high TCR affinity for IAb-PDIA2.
CD44 expression was also increased (Fig. 7 A), indicating some
self-antigen–specific CD4+ T cells in Nfkb2+/Lym1 mice had ac-
quired an antigen-experienced phenotype. In contrast, the size
and phenotype of CD4+ T cell populations specific for a foreign
peptide corresponding to residues 81–95 of GFP (Malhotra et al.,
2016) were comparable in Nfkb2+/+ and Nfkb2+/Lym1 mice (Fig. 7
B). These data show that CD4+ T cell tolerance to the pancreatic
autoantigen, PDIA2, is impaired in Nfkb2+/Lym1 mice.
Increased self-reactivity of T cells selected in the presence of
pathogenic NFKB2/Nfkb2 genotypes
The presence of cysteine and hydrophobic residues at specific
sites in complementarity-determining region 3 (CDR3) of αβ
TCRs promotes T cell self-reactivity (Stadinski et al., 2016;
Wirasinha et al., 2018). As the frequency of these TCR-intrinsic
Figure 5. Autoimmune susceptibility arises
from effects within nonhematopoietic cells.
(A) Posttransplant survival curves of Nfkb2+/+,
Nfkb2+/Lym1 or Nfkb2+/D865G mice, which were αβ
T cell–deficient (Tcra−/−) and aged 63–85 d at
irradiation and reconstitution with T cell–depleted
BM from Nfkb2+/+ or Nfkb2+/Lym1 donors (see key,
middle). (B) Survival curves of Nfkb2+/Lym1 mice
after irradiation and reconstitution with Nfkb2+/+
BMon day 0without further treatment (blue trace)
with some Nfkb2+/Lym1 mice subsequently receiv-
ing FACS-sorted Foxp3GFP+ spleen and lymph node
cells fromWT Foxp3GFPmice at day 8 (red trace). In
the group receiving T reg cells, some recipients
were Tcra−/− and aged 78–122 d, whereas others
were Tcra+/+ and aged 54–88 d, at irradiation.
Since T reg cell transfer prevented disease in three
out of four Tcra−/− recipients and two out of six
Tcra+/+ recipients, these groups were combined.
Other Tcra−/− Nfkb2+/Lym1 mice received whole
Nfkb2+/+ splenocytes on day 0 in the absence of
any other treatment (gray trace). Data in A and B
were combined from two separate experiments
each. Grids show the P values of log-rank tests
comparing each pair of experimental groups.
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Figure 6. Impaired thymic medullary development in mice with p100 degronmutations. (A and B) Thymus sections stained with hematoxylin and eosin
(A; scale bars, 500 µm) with a graph showing the percentage area occupied by the medulla (B). Age did not differ significantly between genotypes (mean ± SD,
110 ± 35 d; range, 55–181 d). (C–E) Immunofluorescence microscopy on thymus sections from mice at 61–86 d of age detecting K8 (cyan) and cytokeratin-14
(K14; magenta; C), UEA-1 (yellow; D), or cytokeratin-5 (K5; magenta) and AIRE (cyan; E); c, cortex; m, medulla; dashed line, corticomedullary border (n = 2 mice
per genotype in a single experiment; scale bars, 50 µm). The detection of different proteins in the same set of sections is shown in C and D. (F and G) Frommice
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motifs varies predictably across T cell subsets in healthy mice
and humans, they serve as biomarkers to diagnose and classify
T cell tolerance defects (Daley et al., 2019). To test whetherNfkb2
or Aire mutations affect the self-reactivity of mature T cell
populations in mice, we sequenced the TCRα and TCRβ reper-
toires of six T cell subsets sorted from the thymus and spleen
(Fig. S3, A and B). In all mouse strains, the percentage of unique
CDR3 sequences with cysteine within two positions of the CDR3
aged 84–133 d, thymic cells released by enzymatic digestion were analyzed by flow cytometry for CD45/EpCAM (F) to identify CD45− EpCAM+ TECs that were
analyzed for binding of UEA-1 and expression of AIRE (G). (H) Plots show the CD19/CD11c phenotype of thymic CD45+ cells with gates for B cells (CD19+) and
DCs (CD11c+). For each subset gated in the plots, graphs show the number of cells per thymus (right). Each symbol in a graph represents an individual mouse
and horizontal bars mark the group mean compiled from two separate experiments. Graphs show data from female and male mice. Each genotype was
compared with the Nfkb2+/+ group using one-way ANOVA with Sidak’s multiple comparisons test; log10-transformed values were used in F–H; *, P < 0.05; ***,
P < 0.001; ****, P < 0.0001.
Figure 7. Increased self-reactivity of T cells selected in the presence of pathogenic NFKB2/Nfkb2 genotypes (see also Fig. S3). (A) After magnetic bead-
based enrichment of IAb-PDIA2 tetramer-binding cells from pooled spleen and lymph nodes, plots show IAb-PDIA2 tetramer staining versus CD44 expression
on CD4+ T cells, with summaries (right) showing the total number of tetramer-binding CD4+ cells detected per mouse, tetramer relative fluorescence intensity
(RFI), and CD44 RFI of the tetramer-binding cells. To calculate RFI, mean fluorescence intensities were divided by the mean ofNfkb2+/+ samples analyzed on the
same day. (B) For mice of the indicated genotypes (top), some of which had been immunized with GFP81–95 emulsified in CFA, plots show IAb-GFP81-95 tetramer
staining versus CD44 expression on CD4+ T cells, with summaries presented as in A (right). In A and B, numbers on plots indicate the number of cells in the gate
shown, and each symbol in a graph represents one mouse while horizontal bars show group means. Age did not differ significantly between genotypes or
peptides (mean ± SD, 135 ± 48 d; range, 63–312 d). Graphs show data from female and male mice compiled from seven (A) or two (B) separate experiments.
(C) For T cell subsets sorted from the thymus or spleen (top) of female mice of the indicated genotypes (color coded, right), graphs show the percentage of
unique TCRα (squares) or TCRβ (circles) sequences with a self-reactivity-promoting amino acid doublet at CDR3 P6-P7 (hydrophobic index; Stadinski et al.,
2016). Age did not differ significantly between genotypes (mean ± SD, 105 ± 12 d; range, 84–120 d). IELp, precursors of CD8αα intestinal intraepithelial
lymphocytes. (D) Hydrophobic index of the TCRβ repertoire of T cell subsets (top) sorted from the blood of healthy control subjects or individuals with
mutations in NFKB2 or AIRE (see key, right). Each symbol represents an individual sample. Statistical comparisons used one-way (A, B, and D) or two-way (C)
ANOVA to compare each group with the control group, followed by Sidak’s multiple comparisons test, using log10-transformed values for tetramer+ cell counts
(A and B) and TCRα and TCRβ values matched by mouse (C); *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
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apex (cysteine index) was highest in thymic type A precursors of
CD8αα intestinal intraepithelial lymphocytes (Fig. S3 C), which
are induced by strong TCR signaling in the thymic cortex
(Ruscher et al., 2017). No strain had an increased cysteine index
in the T reg cell, CD4+ conventional T cell (T conv cell), or CD8+ T
conv cell TCR repertoires (Fig. S3 C). Likewise, the cysteine
index was normal in samples from patients with NFKB2 or AIRE
mutations (Fig. S3, D and E). These genetic lesions do not per-
turb tolerance induction in T cells with cysteine at the
CDR3 apex.
Hydrophobic amino acid doublets at positions 6 and 7 (P6-P7)
of the CDR3 in TCRβ (CDR3β) can promote T cell self-reactivity
(Stadinski et al., 2016). In all mouse strains, the percentage of
unique sequences with a hydrophobic doublet at P6-P7 (hydro-
phobic index) was highest in type A precursor of CD8αα intes-
tinal intraepithelial lymphocytes (Fig. 7 C). While the hydrophobic
indices in Nfkb2+/D865G, Nfkb2xdr/xdr, and Aire−/− mice were normal,
Nfkb2D865G/D865G and Nfkb2+/Lym1 mice had increased hydrophobic
indices in thymic and splenic CD8+ T conv cells, as well as in
splenic CD4+ T conv cells (Fig. 7 C).
After establishing this important signature of defective T cell
self-tolerance inmice with p100 degronmutations, we tested for
a similar change in the peripheral T cell repertoire of patients.
Remarkably, the hydrophobic index was also increased in the
CD4+ T conv cell TCRβ repertoires of patients with heterozygous
NFKB2 mutations, but not in patients with homozygous AIRE
mutations (Fig. 7 D). Thus, in humans and mice, the presence of
pathogenic mutations in the p100 degron results in increased
T cell self-reactivity.
Discussion
Nfkb2 mutations in the p100 degron cause T cell–dependent
autoimmune exocrinopathy, including severe exocrine pancre-
atitis. Pathology involves mTEC and T reg cell developmental
defects that are distinct from those caused by the absence of
p100 and p52 or AIRE. Distinct Nfkb2 degron mutations confer
different extents of degradation resistance on the mutated p100
proteins in a manner that is reflected in the p100/p52 ratio.
Nfkb2 mutations that cause moderate T cell tolerance defects
remain subclinical in B6 mice, but fully penetrant autoimmune
disease develops above a threshold of p100-degradation resis-
tance. T cell central tolerance appears to be exquisitely sensitive
to the IκB function of mutated p100 proteins.
While the defect in thymic tolerance is largely T cell extrinsic
and mediated by changes in thymic epithelium, we also ob-
served T cell–intrinsic defects. Defects in p100 degradation
would be expected to have pleiotropic effects, because NF-κB
members are required for the development of multiple cell types
that establish immune self-tolerance. For example, T cell–
specific deletion of RelA or c-Rel causes graded T reg cell defi-
ciencies, while deletion of both RelA and c-Rel abolishes T reg
cells (Oh et al., 2017). In contrast, T cell–specific or T reg cell–
specific deletion of NF-κB2 causes T reg cell expansion
(Grinberg-Bleyer et al., 2018). Consistent with this, Nfkb2xdr/xdr
cells, which lack NF-κB2, had an enhanced capacity for T reg
cell development in mixed BM chimeras. T reg cell deficiency in
mice bearing the Nfkb2D865G, Nfkb2Lym1, or Nfkb2Y868indel muta-
tions is not consistent with p52 insufficiency; instead, it is
consistent with an exaggerated IκB function of the mutated
p100 proteins, which may sequester RelA and c-Rel in the cy-
toplasm of T cells (Basak et al., 2007; Lee et al., 2014; Savinova
et al., 2009; Scheinman et al., 1993; Sun et al., 1994; Tao et al.,
2014). We interpret the mTEC results similarly. Mice with TEC-
specific deletion of RelA, RelA and c-Rel, or RelB exhibit pro-
gressively more severe blocks in the development of AIRE− and
AIRE+ mTECs (Riemann et al., 2017). Nfkb2+/Lym1 and
Nfkb2D865G/D865G mice have a smaller thymic medulla and fewer
mature (UEA-1hi AIRE− or AIRE+) mTECs than Nfkb2xdr/xdr and
Nfkb2−/− mice. We postulate that mTEC development in Nfkb2+/Lym1
and Nfkb2D865G/D865G mice is blocked because the mutated p100
proteins inhibit RelA, c-Rel, and/or RelB.
AIRE-dependent T reg cell selection in early life is critical to
establish self-tolerance in NOD.Aire−/− mice (Yang et al., 2015).
Autoimmunity caused by AIRE deficiency involves aberrant
thymic selection, into the CD4+ T conv cell lineage, of TCR
specificities normally found in the T reg cell lineage (Malchow
et al., 2016; Perry et al., 2014). A similar misdirection may occur
in Nfkb2D865G/D865G and Nfkb2+/Lym1 mice in which few AIRE+
mTECs are present. However, Nfkb2 degron mutations caused
defects that were not observed in Aire−/− mice, such as thymic
medullary hypoplasia and decreases in the number of UEA1+
Aire− mTECs, B cells, and DCs in the thymus. When transplanted
with WT or BCL2-tg BM, Nfkb2+/D865G and Nfkb2+/Lym1 hosts had
fewer Helios+ Foxp3− cells among CD4SP CCR7+ thymocytes than
WT and Aire−/− hosts, suggesting that the size of the thymic
medulla limits the magnitude of wave 2 deletion. Spontaneous
expansion of high-affinity, IAb-PDIA2–specific, CD4+ T cells in
Nfkb2+/Lym1 mice is consistent with increased escape of self-
reactive T cells from thymic deletion or T reg cell differentia-
tion (Malhotra et al., 2016). As mixed chimeras provided no
evidence that the Nfkb2+/Lym1 genotype confers a thymocyte-
intrinsic defect in deletion, the T cell deletion defect is attrib-
utable to defects in thymic APCs. T cell–extrinsic defects in
Nfkb2+/Lym1 mice are compounded by T cell–intrinsic defects.
Even when selected in the presence of WT thymic APCs,
Nfkb2+/Lym1 T reg cells exhibited a deficit in trans-acting control
of CD4+ CD44high Foxp3− T cell differentiation. TCR sequencing
failed to reveal an effect of AIRE/Aire mutations on the hydro-
phobic index, revealing that this index fails to detect certain
changes in the TCR repertoire (Malchow et al., 2016; Perry et al.,
2014). By contrast, we observed increased hydrophobic indices
in mice with pathogenic Nfkb2 mutations and then confirmed
that this signature could be detected within the TCR repertoire
of humans, indicating that frequent escape of self-reactive
T cells from tolerance mechanisms is a robust marker of thy-
mic dysfunction conferred by severe p100-degradation resis-
tance. Thus, in mice on the B6 genetic background, the
Nfkb2+/Lym1 and Nfkb2D865G/D865G genotypes confer T cell–extrinsic
and T cell–intrinsic self-tolerance defects that are not present in
Aire−/− mice, providing an explanation for the greater severity of
autoimmune manifestations.
Why might the extent of the developmental defect caused by
degradation-resistant p100 differ between cell types? The fate of
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p100 is influenced by the relative concentrations of RelB and the
NIK:IKKα complex, which compete with each other for binding
to p100 (Fusco et al., 2016). RelB diverts p100 into kappaBsomes,
whereas the NIK–IKKα complex phosphorylates p100 to trigger
its degradation (Fusco et al., 2016). The p100 degron is required
for the binding of p100 to IKKα (Xiao et al., 2004) but not for the
binding of p100 to RelB (Fusco et al., 2008). By inhibiting p100
degradation, p100 degron mutations may promote p100 diver-
sion into kappaBsomes in a RelB-regulated manner. Compared
with splenic T reg cells, RelB mRNA expression is 1.7 times
higher in follicular B cells and 7 times higher in mature mTECs
and CD8+ DCs (Heng et al., 2008). Thus, while T reg cell popu-
lation size was decreased by a similar magnitude in all mice with
the Nfkb2D865G, Nfkb2Lym1, or Nfkb2Y868indel alleles, the greater
sensitivity of mTECs, B cells, and DCs in the thymus to severe
p100-degradation resistance may be due to RelB-mediated sta-
bilization of the mutated p100 proteins.
In Nfkb2Ser866fs/S866fs mice, the T reg cell deficiency and trend
toward a reduced thymic medullary area are consistent with
exaggerated IκB function, suggesting that p100S866fs may be
partially resistant to signal-dependent degradation. As these
phenotypes were milder or similar to those of Nfkb2+/D865G and
Nfkb2+/Y868indel mice, it is not surprising that Nfkb2Ser866fs/S866fs
mice did not develop spontaneous autoimmunity. The decreased
abundance of p100 and p52 in Nfkb2Ser866fs/S866fs mice suggests
that the mutated and lengthened C-terminal domain may also
perturb the structural integrity of p100. This is plausible be-
cause the unphosphorylated degron contributes to the interac-
tion between the N- and C-terminal domains of p100 (Qing et al.,
2005). To date, no human NFKB2 mutations that lengthen the
p100 protein have been recognized as pathogenic.
Heterozygous NFKB1 mutations cause clinical manifestations
similar to heterozygous NFKB2 mutations, but distinctions are
emerging. Pathogenic NFKB1 mutations are distributed
throughout the protein and reduce the abundance of p50, sug-
gesting that haploinsufficiency of p50 is pathogenic, although
with incomplete penetrance (Fliegauf et al., 2015; Tuijnenburg
et al., 2018). In contrast, clinically recognized NFKB2 mutations
cluster in the p100 degron (Klemann et al., 2019), consistent with
a distinct underlying mechanism, such as IκB function of the
mutated p100 proteins. Our mouse models have revealed that
autoimmunity caused by p100 degron mutations is T cell de-
pendent but arises largely due to defects in nonhematopoietic
cells. Thus, while successful hematopoietic stem cell transplan-
tation is likely to reduce susceptibility to recurrent infections in
patients with NFKB2 mutations, this treatment may not reduce
susceptibility to autoimmunity. Our findings suggest that sup-




In each experiment, most or all of the mice described as Nfkb2+/+
were siblings of mice with Nfkb2 mutations. As results obtained
from Nfkb2+/+ mice were comparable with B6 mice, which were
used in some experiments, we refer to them collectively as
Nfkb2+/+ (or WT) mice. The Nfkb2Lym1 line was rederived at the
Australian Phenomics Facility, Canberra, using in vitro fertili-
zation with cryopreserved sperm from a Nfkb2+/Lym1 mouse on
the BALB/c background (Tucker et al., 2007). Data were ob-
tained from Nfkb2+/Lym1 mice that were the offspring of ≥6, and
mostly >10, generations of backcrossing to B6. Mice carrying
BCL2-tg (Tg(Vav-BCL2)1Jad), Nfkb2xdr, Aire− (Airetm1Pltn), CD451
(Ptprca), Foxp3GFP (Foxp3tm2Ayr), Foxp3null (Foxp3tm1.1Ayr), H2-Aa−
(H2-Aatm1Blt), B2m− (B2mtm1Jae), or Tcra− (Tcratm1Mom) on the B6
genetic background were bred, intercrossed in some cases, and
housed in specific-pathogen–free environments at 18–24°C and
40–70% humidity with a lighting cycle of 7 a.m. to 7 p.m. light
(below 350 lux) and 7 p.m. to 7 a.m. darkness, at the Australian
Phenomics Facility, Canberra, or at Monash University, Mel-
bourne.Micewere genotyped using PCR assays on genomic DNA
extracted from ear or tail biopsies. All procedures were per-
formed in accordance with protocols approved by The Animal
Experimentation Ethics Committees of the Australian National
University (A2014/62 and A2018/06) or Monash University
(MARP/2015/64). Thymus samples from a single Nfkb2−/−
(Nfkb2tm1Sbn) mouse and its Nfkb2+/+ sibling were provided by
Vanessa Bryant (The Walter and Eliza Hall Institute of Medical
Research, Melbourne, Australia).
The Nfkb2D865G, Nfkb2Y868indel, and Nfkb2S866fs alleles were
generated at the Australian Phenomics Facility, Canberra, using
CRISPR/Cas9 gene editing (Yang et al., 2014). To synthesize Cas9
mRNA, a plasmid encoding Cas9 with a 39 95-nt poly(A) tail
(plasmid 48625:pCAG-T3-hCAS-pA; Addgene) was linearized
with Sph1 (New England Biolabs) and transcribed in vitro using
mMessage mMachine T3 kit (Life Technologies). RNA was
precipitated with absolute ethanol, suspended in RNase-free
water, and stored at −80°C until use. The single guide RNA
(sgRNA) included a sequence corresponding to the target
site in exon 22 of Nfkb2 (59-CTCCACTGACTGGCTCCCAT-39;
protospacer-associated motif italicized and underlined). To syn-
thesize sgRNA, two complementary oligos (Integrated DNA
Technologies) were mixed in the annealing buffer (1 M Tris, pH 8,
1 M MgCl2, 5 M NaCl, and 0.5 M EDTA, pH 8), gently spun down,
heated to 95°C for 5 min, and then cooled by 5°C/min to a final
temperature of 25°C. sgRNA was transcribed using 5–8 µl an-
nealed oligos with the MEGAshort transcription kit (Life Tech-
nologies) followed by alcohol precipitation. The quality and
quantity of Cas9 mRNA and sgRNA were analyzed using Nano
drop and bioanalyzer. The homology-directed repair template was
a 103-base single-stranded sense oligonucleotide with 50-nt arms
corresponding to genomic DNA on either side of the codon with
the desired mutation (GAC>GGC) and harboring a silent mutation
in the protospacer-associated motif sequence (GGG>GGA; under-
lining indicates nucleotides targeted by CRISPR and the desired
change; Integrated DNA Technologies).
Following established protocols (Yang et al., 2014), super-
ovulated B6 (28-d-old) female mice were mated overnight with
B6 male mice. Zygotes were collected at 20 h, and pronuclei-
formed zygotes were put into the M2 medium (Sigma-Aldrich).
After four to six washes in M2 medium at room temperature,
embryos were transferred in to M16 medium that was pre-
calibrated overnight at 37°C. Cas9 mRNA, sgRNA, and the
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homology-directed repair template (100 ng/µl) were mixed, and
∼4 pl was injected into the cytoplasm of each zygote with well-
recognized pronuclei using an Eppendorf micromanipulator.
After injection, all zygotes were cultured overnight in M16 me-
dium at 37°C and 5% CO2. 15–20 fertilized one- or two-cell em-
bryos were transferred into the oviduct of 8-wk-old female Swiss
albino mice mated with vasectomized males the previous night.
For genotyping, ear punches were obtained from 15-d-old pups
and suspended in TE-Tween Lysis Buffer (50 mM Tris HCl, 0.125
mM EDTA, and 2% Tween 20, pH 8.0). 1.0 µl Proteinase K (20
mg/ml) was added to the mix and incubated at 56°C for 1 h fol-
lowed by 99°C for 10 min to denature Proteinase K. 5 µl was used
as a PCR template with the following primers: forward, 59-CCC
TGAAGCCTGAAACCTTGG-39; and reverse, 59-CAGCCTCCACCC
TCATTAAA-39. PCR products were purified using ExoSAP-IT
(Affymetrix), sequenced using the forward primer and results
analyzed with Sequencher software (Gene Codes Corporation). A
founder mouse with the desired Nfkb2D865G substitution, along
with founder mice bearing other substitutions (Nfkb2Y868indel and
Nfkb2S866fs), were backcrossed to B6 to propagate the alleles and a
further two generations of backcrossing were performed before
mice were used for experiments. Effects of variant alleles on
protein sequences were determined using Mutalyzer (https://
mutalyzer.nl).
BM transplantation and adoptive transfers
To make chimeras, recipient mice were irradiated with x rays
(two doses of 4.5 Gy given 4 h apart) and then injected i.v. with
at least 2 × 106 BM cells that had been depleted of T cells using
magnetic beads (Mouse CD3ε Microbead Kit; Miltenyi) and the
“Depl05” program on an autoMACS machine (Miltenyi). To
purify T reg cell cells for adoptive transfer, pooled spleen and
lymph node cells from Foxp3GFP mice were incubated with anti-
CD45R(B220)-biotin (catalog no. 130–101-998; Miltenyi) and
anti-CD8α-biotin (catalog no. 130–118-074; Miltenyi), followed
by incubation with anti-biotinMicroBeads (catalog no. 130–090-
485; Miltenyi) to allow removal of B cells and CD8+ T cells using
the “Deplete” program on an autoMACS machine, before 1 ×
105–2 × 105 FACS-sorted viable CD4+ GFP+ cells were injected i.v.
per recipient.
Immunoblotting
Splenocytes were incubated in lysis buffer (radioimmunopre-
cipitation assay buffer supplemented with 0.5% Protease In-
hibitor [Pierce Net] and 1% Halt Phosphatase Inhibitor Cocktail
[Thermo Fisher Scientific]) for 30 min on ice and then centri-
fuged at 16,000 g for 10 min at 4°C. Supernatant was harvested
and protein concentration estimated using a DC protein assay
(Bio-Rad). 50 µg of total protein was combined with LDS Sample
Buffer and Sample Reducing Agent (Thermo Fisher Scientific)
and boiled at 100°C for 10 min. Samples were then subjected to
SDS-PAGE followed by wet transfer to polyvinylidene difluoride
membrane. Membranes were blocked for 1 h at room tempera-
ture with 2.5% BSA in Tris-buffered saline with 0.1% Tween-20
(TBS-T) before overnight incubation with rabbit anti-p100/p52
(catalog no. 4882; Cell Signaling Technology) diluted 1:1,000 in
5% BSA in TBS-T, followed by 1 h in HRP-conjugated anti-rabbit
IgG (catalog no. ab6795; Abcam) diluted 1:9,000 in 5% BSA in
TBS-T, mouse anti-GAPDH (catalog no. ab8245; Abcam), and
HRP-conjugated goat anti-mouse IgG (catalog no. sc-2005; Santa
Cruz), diluted 1:3,000 in 5% skim milk in TBS-T, and incubated
sequentially for 1 h each. Membranes were imaged using
Amersham ECL detection agents (GE Lifesciences) and chemi-
luminescence detected on a FujiFilm LAS-4000 camera. Protein
density was analyzed with ImageJ analysis software (Schneider
et al., 2012). Density histograms were plotted for each lane.
Histogram peaks for p100, p52, and GAPDHwere identified at 98
kD, 49 kD, and 38 kD, respectively. The areas for the p100 and
p52 peaks were divided by the area of GAPDH to control for
differences in quantity of sample loaded. Each value was then
divided by the (mean of) WT lane(s) to obtain a normalized
density; p100/p52 ratios were calculated directly, ignoring
GAPDH.
Histology
Organs were fixed in 10% neutral buffered formalin and em-
bedded in paraffin, and 4-µm sections were stained with he-
matoxylin and eosin. Pathology was scored as the average of two
or three observers, blinded to animal identifiers, with the fol-
lowing rubric: 0, section shows normal tissue free of inflam-
matory infiltrates; 1, section shows one or two inflammatory
foci, typically with a perivascular distribution; 2, section shows
more than two inflammatory foci, with no significant lesions in
tissue parenchyma; 3, section shows <50% tissue occupied by
lesions including inflammatory infiltrates; 4, section shows
>50% lesions with or without inflammatory infiltrates. Lesions
in the pancreas/lacrimal gland/salivary gland included acinar
cell effacement with preservation of ducts with or without re-
placement with fat or fibroblasts and in lung included collapse,
congestion, emphysema, consolidation, or fibrosis. Thymic
medullary areas were determined in a genotype-blindedmanner
using the Lasso tool and Measurement function in Adobe Pho-
toshop. In addition, 11 livemicewere submitted to the Australian
Phenomics Network Histopathology and Organ Pathology Ser-
vice, University of Melbourne, Australia, for comprehensive
pre- and postmortem examination.
Flow cytometry including EdU labeling
For CCR7 staining, single-cell thymocyte suspensions were in-
cubated for 60 min at 37°C in prewarmed FACS buffer (PBS
containing 2% vol/vol heat-inactivated bovine serum and 0.01%
mass/vol sodium azide) containing fluorochrome- or biotin-
conjugated anti-CCR7 (catalog no. 120104 or 120105; Bio-
Legend). Cells were pelleted by centrifugation and incubated
for 30 min in FACS buffer at 4°C containing assortments of
antibodies against TCRβ (catalog no. 109233 or 109234; Bio-
Legend), CD5 (Miltenyi, catalog no. 130–103-796), CD4 (catalog
no. 100430; BioLegend), CD8α (catalog no. 100766; BioLegend),
CD44 (catalog no. 103039; BioLegend), and B220 (catalog no.
103222; BioLegend). After washing in FACS buffer, cells were
fixed and permeabilized using the Foxp3/Transcription Factor
Staining Buffer Set (catalog no. 00–5523-00; Thermo Fisher
Scientific) and then incubatedwith antibodies specific for Helios
(catalog no. 137220 or 137222; BioLegend) or Foxp3 (catalog no.
Wirasinha et al. Journal of Experimental Medicine 14 of 19








niversity Library user on 04 February 2021
11–5773-80; Thermo Fisher Scientific). In some experiments,
0.25 mg EdU in PBS was injected i.v. either 3 d or 5 d before
analysis as described in the figure legends, in which case thy-
mocyte samples were then processed using the Click-iT EdU
Flow Cytometry Assay Kit (catalog no. C10420 or C10635;
Thermo Fisher Scientific) following the manufacturer’s in-
structions except that Click-iT EdU buffer additive (Component
G) was used at one-fifth of the concentration recommended.
Samples were then washed in FACS buffer and incubated with
streptavidin-PE or -BV650 (catalog no. 405204 or 405232; Bio-
Legend). Human peripheral blood mononucleated cells were
isolated by density gradient centrifugation on Ficoll, washed
with FACS buffer, and maintained at 4°C. The following anti-
bodies were used: CD19 (SJ25C1), CD3 (HIT3A), CD4 (SK3), CD8
(SK1), and CD25 (2A3; all from BD Biosciences) and CD127
(A7R34; eBioscience). After washing in FACS buffer, data were
acquired with LSR II flow cytometers (Becton Dickinson) and
analyzed using FlowJo software (FlowJo).
Immunofluorescence
Thymi were dissected, embedded in Tissue-Tek O.C.T com-
pound (Sakura Finetek), snap frozen in a liquid nitrogen/iso-
pentane slurry, and stored at −80°C before use. Samples were
cut into 8-µm cryosections using a Micron HM550 Cryostat
(Thermo Fisher Scientific), air dried, fixed in ice-cold acetone
for 1 min, air dried, and blocked with 5% (vol/vol) goat serum in
PBS with 0.5% Tween-20 (vol/vol) for 30 min at room tem-
perature. Sections were incubated for 30 min at room temper-
ature with primary antibodies, including anti-K5 (catalog no.
905504; BioLegend), anti-K14 (catalog no. 90530; BioLegend),
biotinylated UEA-1 lectin (catalog no. B-1065; Vector Laborato-
ries), biotinylated anti-mouse AIRE (clone 5H12; Walter and
Eliza Hall Institute), and anti-K8 (clone TROMA-I; Develop-
mental Studies Hybridoma Bank). Following three 5-min washes
in PBS, sections were incubated with secondary reagents in-
cluding Donkey anti-rabbit IgG Alexa Fluor 555 (catalog no. A-
31572; Invitrogen); Goat anti-rat IgG Alexa Fluor 555 (catalog no.
A-21434; Invitrogen); Donkey anti-rabbit IgG Alexa Fluor 647
(catalog no. A-21244; Invitrogen), and Alexa Fluor 488 conju-
gated streptavidin (catalog no. S32354; Invitrogen) for 30 min at
room temperature. Sections were then washed with PBS,
counterstained with 300 nM DAPI (Sigma-Aldrich), and moun-
ted with Vectashield (Vector Laboratories). Images were col-
lected using an LSM780 or LSM880 confocal microscope with
Zen 2012 SP2 (black) software v11.0 (Zeiss). Single optical
sections were processed for presentation using OMERO (Allan
et al., 2012) and FIJI (Schindelin et al., 2012).
Thymus digestion and flow cytometry
This procedure is described in detail elsewhere (Jain and Gray,
2014). Briefly, the thymic lobes were separated and cleaned of
connective tissue. Snips were made in lobes with scissors, and
the fragments were triturated in 5 ml RPMI-1640 medium with
25.96 mM Hepes with a wide-bore pipette tip. The supernatant
was recovered and replaced by 1 ml digestion buffer (RPMI-
Hepes supplemented with 0.5 Wunsch units of Liberase TM
[Roche] and 0.1% wt/vol DNase I [Sigma-Aldrich]). Thymic
tissue was digested at 37°C for 15 min with periodic gentle
trituration. At the end of the first digestion, the supernatant was
recovered, stored on ice (fraction 1), and replaced with 500 µl
fresh digestion buffer. Digestion was repeated at 37°C with
gentle agitation after every 5 min until a single-cell suspension
was obtained (fraction 2). Cells in all fractions were counted
before staining for flow cytometry. Surface staining of TECs
was performed using the following antibodies for 20 min on ice:
anti-mouse CD45 PerCP/Cy5.5 (catalog no. 103132; BioLegend),
anti-mouse CD326 (EpCAM) APC/Cy7 (catalog no. 118218; Bio-
Legend), and biotinylated UEA-1 lectin (catalog no. B-1065;
Vector Laboratories). Intracellular staining with anti-mouse
AIRE-A647 (clone 5H12; Walter and Eliza Hall Institute) was
performed after fixation and permeabilization with the eBio-
science Foxp3/Transcription Factor Staining Buffer Set (catalog
no. 00–5523-00; Thermo Fisher Scientific). Secondary detection
of biotinylated UEA-1 was performed with Alexa Fluor 488–
conjugated streptavidin (catalog no. S32354; Thermo Fisher
Scientific). To quantify thymic B cells and DCs, supernatants
recovered from the first trituration step and fraction 1 were
stained separately with anti-mouse CD45 PerCP/Cy5.5 (Bio-
Legend), anti-mouse CD19 PE (catalog no. 115508; BioLegend),
and anti-mouse CD11c PE/Cy7 (catalog no. 117318; BioLegend)
before flow cytometry data were acquired and analyzed as
above.
Peptide/MHC class II tetramer synthesis
The regions encoding the extracellular domains of the IAb α- and
β-chains were cloned into a modified pFastBac Dual vector (In-
vitrogen). The IAb α-chain, driven by the polyhedrin promoter,
was cloned in frame between a sequence encoding the baculovirus
gp67 signal peptide and an enterokinase-cleavable fos-leucine
zipper region. The IAb β-chain encoded a factor Xa–cleavable
N-terminal glycine-serine linker. This modified IAb β-chain was
cloned, in front of the p10 promoter, in frame between a sequence
encoding the baculovirus gp67 signal peptide and an enterokinase-
cleavable jun leucine zipper region, followed by a BirA recognition
sequence and a poly-histidine tag. Sequences encoding peptides for
mouse PDIA2 residues 83–93, EYSKAAALLAA (reference sequence
NP_001074539.1) or GFP residues 81–95, HDFFKSAMPEGYVQE
(reference sequence AMQ45836.1) were cloned in frame between
the region encoding the gp67 signal peptide and the N-terminal
glycine-serine linker of the IAb β-chain. This construct was used in
the Bac-to-Bac system (Invitrogen) to produce recombinant virus
as described by themanufacturer, with the exception that a DH10B
strain harboring a chitinase/vcathepsin-negative AcMNPV bacmid
(AcBACΔCC; Kaba et al., 2004) was used in place of DH10Bac cells.
The resultant virus was used to infect High Five insect cells (Tri-
choplusia ni BTI-TN-5B1-4 cells; Invitrogen) for the production of
IAb-PDIA283–93 and IAb-GFP81–95 proteins. Supernatants were har-
vested 48 h after infection, concentrated, and diafiltered using a
tangential flow filtration system (Cogent M1; Merck-Millipore).
Recombinant IAb was purified from the diafiltered supernatant
using Ni NTA Agarose (Qiagen) and further purified by gel filtra-
tion and ion exchange chromatography on Superdex 200 16/60
and HiTrap Q HP columns (GE Biosciences), respectively. Proteins
were buffer exchanged into 10mMTris, pH 8.0, biotinylated using
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BirA ligase, desalted in PBS to remove excess biotin, and tetra-
merized by addition of Streptavidin-PE or Streptavidin-APC (BD
Biosciences) at a 4:1 molar ratio.
Detection of peptide/MHC class II–specific T cells
Peptide/MHC class II–specific CD4+ T cell populations were
enumerated using tetramer-based magnetic enrichment (Moon
et al., 2007). Briefly, the spleen and major lymph nodes (auxil-
iary, brachial, cervical, inguinal, and mesenteric) from individ-
ual mice were pooled and stained with PE-labeled or APC-labeled
peptide/MHC class II tetramers. Cells were washed and incu-
bated with anti-PE or anti-APC microbeads (Miltenyi), and
tetramer-bound cells were enriched using a magnetic LS column
(Miltenyi). Enriched cells were stained with antibodies specific
for CD4, CD8α, TCRβ, CD44, CD11b, CD11c, B220, F4/80, and
NK1.1 and analyzed using a BD LSRFortessa X-20 flow cytometer.
To elicit IAb-GFP81–95 specific T cells, mice were anaesthetized
with isoflurane and immunized subcutaneously at two sites with
a total of 100 µg GFP81–95 peptide emulsified in a 1:1 ratio with
complete Freund’s adjuvant 14 d before analysis.
Human TCR sequencing
Peripheral blood mononuclear cells were obtained from patients
and healthy donors upon informed consent, and the study was
approved by the Institutional Review Board of the National In-
stitutes of Health (protocols 18-I-0041 and 16-I-N139) or the
Human Research Ethics Committee of the Canberra Hospital
(ETH1.15.015). CD4− CD8+ (CD8+ T conv), CD4+ CD8− CD127+
CD25− (CD4+ T conv), and CD4+ CD8− CD127− CD25+ (T reg) cells
were sorted using the gating strategy shown in Fig. S3 D. For
samples from two patients with AIRE mutations (identified as
PTCID02 and PTCID03), methods used to amplify and sequence
TCRβmRNA transcripts were described previously (Daley et al.,
2019). For all other human T cell samples, TCRβ genes were
amplified using proprietary, multiplex PCR protocols with either
genomic DNA (Adaptive Biotechnologies) or mRNA (iRepertoire)
as template. The PCR products were sequenced using the Il-
lumina HiSeq platform. Custom algorithms (Adaptive Bio-
technologies or iRepertoire) were used to filter the raw
sequences for errors and to align the sequences to reference
genome sequences.
Mouse TCR sequence acquisition and filtering
T cells were sorted from the thymus and spleen according to the
gating strategy shown in Fig. S3, A and B. Methods used for RNA
isolation, cDNA synthesis, PCR amplification of TCRα and TCRβ
transcripts, addition of sequencing adapters and sample indices,
amplicon concentration, purification, sequencing, and align-
ment to mouse genome using molecular identifier groups–based
error correction software (Shugay et al., 2014) were described
previously (Wirasinha et al., 2018). Primers are listed in Table
S2. Sequences with a CDR3 that was out of frame or contained a
stop codon were excluded. To avoid overestimating TCR diver-
sity due to PCR or sequencing errors, sequences detected only
once in any given sample were excluded. A unique sequence was
defined as a unique combination of Trav or Trbv gene and CDR3
nucleotide sequence.
TCR sequence analyses
For hydrophobic and cysteine index analyses, CDR3 sequences
<8 aawere excluded because a conserved Phe or Try is present at
position 6 or 7 of CDR3 sequences that are 6 or 7 aa long. The
hydrophobic index equals the percentage of unique clonotypes
with a CDR3 P6-P7 doublet corresponding to any of the 175 aa
doublets identified as promoting self-reactivity when present at
CDR3β P6-P7 (Stadinski et al., 2016). The cysteine index equals
the percentage of unique clonotypes with cysteine within two
positions of the CDR3 apex. Briefly, for a CDR3 sequence of n
amino acids, the amino acid at the largest position not greater
than (n/2 + 1) was defined as the CDR3 apex (Wirasinha et al.,
2018).
Data visualization and statistical analyses
The “tidyverse,” “stringr,” “survival,” and “reshape2” packages
were used to perform TCR sequence analyses, conduct Pearson’s
tests for correlation, and produce graphs in RStudio. Statistical
analyses were performed using GraphPad Prism version 7.0a
(GraphPad Software) with multiple comparisons tests recom-
mended by GraphPad Prism. Figures were made using Adobe
Illustrator (Adobe Systems).
Materials availability
Mouse strains generated in this study are available from the
Australian Phenomics Facility with a completed Materials
Transfer Agreement.
Data and code availability
TCR sequencing data have been deposited in the NCBI Short
Read Archive under BioProject numbers PRJNA606989 (mouse)
and PRJNA606976 (human subjects PTCID02 and PTCID03).
Refer to the Monash University data repository digital object
identifier 10.26180/5e4a78acb70ef for the code for calculating
cysteine and hydrophobic indices and the digital object identifier
10.26180/5da7d4b26478f for the filtered list of mouse TCR clo-
notypes plus a summary of the TCR-sequencing results at the
individual-sample level.
Online supplemental material
Fig. S1 shows NFKB2/Nfkb2 variants and statistical analysis of
lifespan in the murine Nfkb2 allelic series. Fig. S2 shows gating
strategies to quantify thymic deletion at waves 1 and 2. Fig. S3
shows the T cell sorting gates for TCR-sequencing and cysteine
index results. Table S1 shows the NFKB2 and AIREmutations and
clinical manifestations observed in patients examined. Table S2
lists primers used to amplify mouse Tcra and Tcrb transcripts.
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Figure S1. NFKB2/Nfkb2 variants and statistical analysis of lifespan in the murine Nfkb2 allelic series (related to Fig. 1). (A) Sanger sequencing
chromatograms for DNA encoding the p100 degron of a control B6 mouse (Nfkb2+/+) and mice of the indicated Nfkb2 genotypes generated in this study. (B) For
pairs of survival curves shown in Fig. 1, B and C, the grid shows the P values of log-rank tests. (C) NFKB2 variants identified in patients, including effects of
variants on expression and phosphorylation of the mutant precursor protein and on p52 expression, as well as the reference. NA, not available.
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Figure S2. Quantification of thymic deletion at waves 1 and 2 (related to Fig. 3). (A and B) Thymocyte phenotypes of Nfkb2+/+ and Nfkb2+/D865G mice,
which were negative or positive for BCL2-tg (top), 3 d after a single dose of EdU. (A) Forward scatter (FSC) versus EdU on all thymocytes with a gate for EdU+
cells, including a negative control sample from an uninjected mouse (column 6). (B) CD5/TCRβ phenotype of EdU+ thymocytes with a gate to identify CD5+
TCRβ+ (TCR-signaled) cells, including a negative control sample from a Tcra–/–mouse (column 5). (C and D) Nfkb2+/+ and Nfkb2+/Lym1mice, which were negative
or positive for BCL2-tg (top), were examined as above in A and B. A BCL2-tg+ B2m–/– H2-Aa–/– mouse was used as a negative control for the gating of CD5+
TCRβ+ cells (column 5). (E–G)Mice of the indicated genotypes were injected with a single dose of EdU and thymocytes were analysed 5 d later. (E) FSC versus
EdU on all thymocytes with a gate for EdU+ cells. (F and G) Plots show gating of CD5+ TCRβ+ cells among EdU+ thymocytes (F) and CD4+ CD8α− cells among
EdU+ CD5+ TCRβ+ thymocytes (G). Each symbol in a graph (right) represents a measurement from one mouse and horizontal bars show the group means. Data
in A and B, C and D, and E–G were compiled from two separate experiments each. Statistical comparisons used one-way ANOVA with Sidak’s multiple
comparisons tests; *, P < 0.05; **, P < 0.01.
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Figure S3. T cell sorting gates for TCR-sequencing and cysteine index results (related to Fig. 7). (A and B) Flow cytometry gates used to sort T cell
subsets from (A) thymus and (B) spleen of female Nfkb2+/+, Nfkb2+/D865G, Nfkb2D865G/D865G, Nfkb2+/Lym1, Nfkb2xdr/xdr, and Aire−/− mice aged 84–120 d (n = 3/
genotype). (C) For T cell subsets sorted from the thymus or spleen (top) of mice of the indicated genotypes (color coded, right), graphs show the percentage of
unique TCRα (squares) or TCRβ (circles) sequences with cysteine within two positions of the CDR3 apex (cysteine index). (D) Gating strategy to sort T cell
subsets from human PBMC for TCR sequencing. (E) Cysteine index of T cell subsets (bottom) sorted from PBMC of healthy control subjects or individuals with
mutations in NFKB2 or AIRE (see key, right). In C and E, filled symbols indicate samples that had zero sequences with cysteine within two positions of the CDR3
apex; in these cases, the symbols represent the reciprocal of the number of unique sequences in the sample, expressed as a percentage; *, P < 0.05; one-way
ANOVA with Sidak’s multiple comparisons test.
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Tables S1 and S2 are provided online as separate Word documents. Table S1 lists the clinical manifestations in patients with
mutations in AIRE or NFKB2. Table S2 lists the primers used to amplify mouse Tcra and Tcrb transcripts.
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